10:15 AM EST - Revive Therapeutics Ltd. : Announced the advancement of the research program to evaluate Cannabidiol in the treatment of Autoimmune Hepatitis, a rare liver disease. The research will be overseen by Sanyal Biotechnology LLC, the Company’s strategic research partner for liver diseases. Revive Therapeutics Ltd.
shares V.RVV are trading down $0.005 at $0.34.
